A case of Wilms tumour recurrance successfully treatment
https://doi.org/10.17650/2311-1267-2017-4-4-74-77
Abstract
Patients’ survival with nephroblastoma improved dramatically with a multimodal treatment. Wilms tumour (WT) relapses occur during 18 months of follow up in a tumour bad or/and in lungs in most cases. Herein we present a case of patient with a late nephroblastoma recurrence locally, in irradiated field, and with metastasis in a right liver lobe. Primary treatment included: urgent surgery (nephrectomy), irradiation of a tumour bad, paraaortic lymph nodes, a left abdominal flank (29–33 Gr); and chemotherapy (vincristine, actinomycin D and adriamycin) according the protocol SIOP WT 2001 recommendations for stage III. A boy was 5 years old when WT was diagnosed. The patient developed relapse 18 months later a primary surgery. A tumour’s volume has been decreased dramatically after 3 courses (ICE – ifosfamide, carboplatin, etoposide) of neoadjuvant chemotherapy. A left retroabdominal mass, a left ureteral stump and a right liver lobe (V, VI, VII) were removed during a surgery followed by 2 courses of adjuvant chemotherapy (ICE). The radiotherapy was avoided because of a primary irradiation. After 18 months of follow up the patient is in a second remission.
About the Authors
L. I. ShatsRussian Federation
2 Litovskaya St., St. Petersburg, 194100, Russia
V. B. Silkov
Russian Federation
2 Litovskaya St., St. Petersburg, 194100, Russia
A. M. Mitrofanova
Russian Federation
1 Samory Mashela St., Moscow, 117997, Russia
M. B. Belogurova
Russian Federation
2 Litovskaya St., St. Petersburg, 194100, Russia
References
1. Brok J., Treger T.D., Gooskens S.L., van den Heuvel-Eibrink M.M., Pritchard-Jones K. Biology and treatment of renal tumours in childhood. Eur J Cancer 2016;68:179–95. doi: 10.1016/j.ejca.2016.09.005.
2. Kieran K., Ehrlich P.F. Current surgical standards of care in Wilms tumor. Urol Oncol 2016;34(1):13–23. doi: 10.1016/j.urolonc.2015.05.029.
3. Malogolowkin M., Cotton C.A., Green D.M. et al.; National Wilms Tumor Study Group. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 2008;50(2):236–41. doi: 10.1002/pbc.21267.
4. Spreafico F., Pritchard Jones K., Malogolowkin M.H. et al. Treatment of relapsed Wilms tumors: lessons learned. Expert Rev Anticancer Ther 2009;9(12):1807–15. doi: 10.1586/era.09.159.
5. Shamberger R.C., Guthrie K.A., Ritchey M.L. et al. Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4. Ann Surg 1999;229(2):292–7. PMCID: PMC1191644.
6. Pein F., Rey A., de Kraker J. et al. Multivariate analysis of adverse prognostic factors (APF) in children with recurrent (Rec) Wilms’ tumor (WT) after initial treatment according to SIOP- 6 or SIOP-9 strategies. Med Pediatr Oncol 1999;33:170; abstr. 11.
7. Vujanić G.M., Sandstedt B., Harms D. et al.; SIOP Nephroblastoma Scientific Committee. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. Med Pediatr Oncol 2002;38(2):79–82. PMID: 11813170.
8. Reinhard H., Schmidt A., Furtwängler R. et al. Outcome of relapses of nephroblastoma in patients registered in the SIOP/GPOH trials and studies. Oncol Rep 2008;20(2):463–7. PMID: 18636212.
Review
For citations:
Shats L.I., Silkov V.B., Mitrofanova A.M., Belogurova M.B. A case of Wilms tumour recurrance successfully treatment. Russian Journal of Pediatric Hematology and Oncology. 2017;4(4):74-77. (In Russ.) https://doi.org/10.17650/2311-1267-2017-4-4-74-77